We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway.
- Authors
Ming-de Zang; Lei Hu; Zhi-yuan Fan; He-xiao Wang; Zheng-lun Zhu; Shu Cao; Xiong-yan Wu; Jian-fang Li; Li-ping Su; Chen Li; Zheng-gang Zhu; Min Yan; Bing-ya Liu; Zang, Ming-de; Hu, Lei; Fan, Zhi-Yuan; Wang, He-Xiao; Zhu, Zheng-Lun; Cao, Shu; Wu, Xiong-Yan
- Abstract
<bold>Background: </bold>Gastric cancer (GC) is one of the most malignant tumors and the second leading cause of cancer-related deaths in the world. Luteolin, a flavonoid present in many fruits and green plants, suppresses cancer progression. The effects of luteolin on GC cells and their underlying mechanisms remain unclear.<bold>Methods: </bold>Effects of luteolin on cell proliferation, migration, invasion, and apoptosis were examined in vitro and in vivo by cell counting kit-8 (CCK-8), transwell assays, and flow cytometry, respectively. Real-time reverse transcription polymerase chain reaction (RT-PCR) and Western blots were performed to evaluate Notch1 signaling and activation of epithelial-mesenchymal transition (EMT) in GC cells treated with or without luteolin. Immunohistochemistry was performed to examine proliferation and Notch1 expression in xenograft tumors.<bold>Results: </bold>Luteolin significantly inhibited cell proliferation, invasion, and migration in a dose-dependent and time-dependent manner and promoted cell apoptosis. Luteolin reversed EMT by shrinking the cytoskeleton and by inducing the expression of epithelial biomarker E-cadherin and downregulating the mesenchymal biomarkers N-cadherin, vimentin and Snail. Furthermore, Notch1 signaling was inhibited by luteolin, and downregulation of Notch1 had similar effects as luteolin treatment on cell proliferation, migration, and apoptosis. In addition, luteolin suppressed tumor growth in vivo. A higher expression of Notch1 correlated with a poor overall survival and a poor time to first progression. Furthermore, co-immunoprecipitation analysis revealed that activated Notch1 and β-catenin formed a complex and regulated cell proliferation, migration, and invasion.<bold>Conclusions: </bold>In this study, GC progression was inhibited by luteolin through suppressing Notch1 signaling and reversing EMT, suggesting that luteolin may serve as an effective anti-tumor drug in GC treatment.
- Subjects
LUTEOLIN; CANCER invasiveness; CARCINOGENS; INCURABLE diseases; GASTRIC diseases; ANIMAL experimentation; APOPTOSIS; BIOLOGICAL models; CELL lines; CELL physiology; CELL receptors; CELL motility; CELLULAR signal transduction; CYTOPLASM; MICE; PROGNOSIS; STOMACH tumors; DISEASE progression; COLONY-forming units assay; FLAVONES; THERAPEUTICS
- Publication
Journal of Translational Medicine, 2017, Vol 15, p1
- ISSN
1479-5876
- Publication type
journal article
- DOI
10.1186/s12967-017-1151-6